Dr. Steven Greer’s previous works, SIRIUS and UNACKNOWLEDGED, broke crowdfunding records and ignited a grassroots movement. CLOSE ENCOUNTERS OF THE FIFTH KIND features groundbreaking video and photographic evidence and supporting interviews from prominent figures such as Adam Curry of Princeton’s PEAR Lab; legendary civil rights attorney Daniel Sheehan, and Dr. Russell Targ, who headed the CIA’s top secret remote viewing program. Their message: For thousands of people, contact has begun. This is their story.
You May Also Like
What once seemed like an esoteric world now seems essential to our culture: the community of rare book dealers and collectors who, in their love of the delicacy and tactility of books, are helping to keep the printed word alive. D.W. Young’s elegant and entertaining documentary, executive produced by Parker Posey, is a lively tour of New York’s book world, past and present, from the Park Avenue Armory’s annual Antiquarian Book Fair, where original editions can fetch hundreds of thousands of dollars; to the Strand and Argosy book stores, still standing against all odds; to the beautifully crammed apartments of collectors and buyers. The film features a litany of special guests, including Fran Lebowitz, Susan Orlean, Gay Talese, and a community of dedicated book dealers who strongly believe in the wonder of the object and the everlasting importance of what’s inside.
Twenty five years after Miguel died from AIDS, his niece, filmmaker Cecilia Aldarondo, embarks on an excavation into a quagmire of unresolved family drama. Like many gay men in the 1980s, Miguel moved from Puerto Rico to New York City; he found a career in theater and a rewarding relationship. Yet, on his deathbed he grappled to reconcile his homosexuality with his Catholic upbringing. Now, decades after his death, Cecilia locates Miguel’s lover Robert, who has been shunned and demonized by the family, in order to understand the whole story.
Here comes DEATH’s probing and pulsing rock doc, DEATH BY METAL, pulling back the palm fronds of DEATH’s origins in Altamonte Springs, Florida, and latching a narrative hook into the headstrong Chuck Schuldiner juggernaut for fifteen gratifying if sometimes frustrating years. As the baby steps become giant leaps, the stable of supporting players grows and continually shines in its own devious light.
Five unique individuals in pursuit of a big life change. Through auditions set up in small towns across Southern California, the film shows genuine characters with big Hollywood aspirations who, for various reasons, have never had the opportunity to pursue their dreams.
One in four women experience violence in their homes. Have you ever asked, “Why doesn’t she just leave?” Private Violence shatters the brutality of our logic and intimately reveals the stories of two women: Deanna Walters, who transforms from victim to survivor, and Kit Gruelle, who advocates for justice.
This lively documentary explores the rise and fall of physical media from the origin of film all the way through the video store era into digital media, focusing on B-movie and cult films. With icons like Joe Bob Briggs (MonsterVision), Lloyd Kaufman (Toxic Avenger), Greg Sestero (The Room), Debbie Rochon (Return to Nuke ‘Em High), Deborah Reed (Troll 2), Mark Frazer (Samurai Cop), James Nguyen (Birdemic) and many others.
A look at the intersection of religion and activism, tracing the rise of The Satanic Temple: only six years old and already one of the most controversial religious movements in American history. The Temple is calling for a Satanic revolution to save the nation’s soul. But are they for real?
Burzynski, the Movie is the story of a medical doctor and Ph.D biochemist named Dr. Stanislaw Burzynski who won the largest, and possibly the most convoluted and intriguing legal battle against the Food & Drug Administration in American history. His victorious battles with the United States government were centered around Dr. Burzynski’s gene-targeted cancer medicines he discovered in the 1970’s called Antineoplastons, which have currently completed Phase II FDA-supervised clinical trials in 2009 and could begin the final phase of FDA testing in 2011–barring the ability to raise the required $300 million to fund the final phase of FDA clinical trials.